BCG adjuvant therapy in stage D prostatic carcinoma.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009439:Neuraminidase / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000556:secondary / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D009439:Neuraminidase